Human B7-H2 is a member of the growing B7 family of immune costimulatory proteins. Other family members include B7-1, B7-2, B7-H1 (PD-L1), PD-L2 and B7-H3. B7 proteins are members of the immunoglobulin (Ig) superfamily, the extracellular domains contain 2 Ig-like domains and all members have short cytoplasmic domains. B7-H2 has been identified as the ligand for ICOS, a member of the CD28 family of costimulatory receptors. Human B7-H2 is expressed constitutively on resting B cells, dendritic cells and at low levels on monocytes. The B7-H2/ICOS interaction appears to play roles in T cell dependent B cell activation and Th differentiation.
Sequence
The extracellular domain of human CD275 [B7-H2] (aa 1-256) is fused to the N-terminus of the Fc region of human IgG1.
Crossreactivity
Human
Biological Activity
Measured by its ability to stimulate human T cell proliferation in the presence of anti-CD3.
Purity
≥98% (SDS-PAGE)
Endotoxin Content
<0.06EU/μg protein (LAL test; Lonza).
Reconstitution
Reconstitute with 100 µl sterile water. Add 1X PBS to the desired protein concentration.
CD28 (human):Fc (human) (rec.) | CHI-HF-210CD28
CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell...
CD28 (human):Fc (human) (rec.) | CHI-HF-210CD28
CD28 and CTLA-4 together with their ligands, CD80 (B7-1) and CD86 (B7-2), constitute one of the dominantcostimulatory pathways that regulate T and B...
CD152 [CTLA-4] (mouse):Fc (mouse) (rec.) | CHI-MF-110A4-C100
CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate...